Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment

• Główni autorzy: Hung-Jun Lin (Autor), Tien-Li Liang (Autor), Yao-Yuan Chang (Autor), Der-Zen Liu (Autor), Jia-Yu Fan (Autor), Steve R. Roffler (Autor), Shyr-Yi Lin (Autor)
• Format: Książka
• Wydane: MDPI AG, 2022-06-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Pancreatic cancer is one of the most common causes of death in Taiwan. Previous studies have shown that more than 90% of pancreatic cancer cells presented epidermal growth factor receptor (EGFR) cell marker, and this marker is thought to be important as it is related to activation of cancer cell pro...